Lianhe Aigen Pharma Co., Ltd. is a leading provider of innovative drug solutions at home and abroad. Shanghai R&D center, Lianhe Aigen Pharmatech Co., Ltd., as a CRO platform, provides preclinical new drug discovery services for global customers. Taizhou Site, Lianhe Aigen Pharma Co., Ltd. (formerly known as Lianhe Chemical Technology (Taizhou) Co., Ltd.), as a CDMO platform, relies on its leading integrated customized service capabilities and perfect quality management system, and is jointly committed to providing one-stop CRDMO services including new drug discovery, preclinical, clinical and commercial stages for the world's leading innovative pharmaceutical companies, empowering global innovative drugs and contributing to human health.

Founded in 2010, we focus on pharmaceutical Contract Development and Manufacturing Organization (CDMO) service. Our facilities are successfully inspected by the FDA, EMA, PMDA, TGA, KFDA and NMPA. Customer care is our top priority. With continuous improvement of technological innovation capabilities, efficient production management system, strict quality assurance system, high-standard safety and environmental protection management system, reliable and perfect supply chain management system, high-quality and efficient customer service, we have become an important strategic partner of the world's leading pharmaceutical companies.

We practice green development and always adhere to the integration of ESG management into our operations. We actively improve the ESG management level of the company, enhance the company's sustainable development ability, continue to create value for customers and society, and help of more good drugs benefit the public earlier.